Lorinda Chung Selected Research

Raynaud Disease (Raynaud's Disease)

6/2014	Multicriteria decision analysis methods with 1000Minds for developing systemic sclerosis classification criteria.
10/2008	Malignancy in the setting of the anti-synthetase syndrome.
6/2007	Therapeutic options for digital ulcers in patients with systemic sclerosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lorinda Chung Research Topics

Disease

34	Systemic Scleroderma (Systemic Sclerosis) 05/2022 - 05/2006
14	Dermatomyositis (Dermatopolymyositis) 07/2022 - 06/2007
14	Pulmonary Arterial Hypertension 01/2022 - 09/2006
11	Calcinosis 02/2022 - 06/2014
9	Inflammation (Inflammations) 05/2022 - 06/2011
9	Interstitial Lung Diseases (Interstitial Lung Disease) 03/2021 - 07/2011
8	Fibrosis (Cirrhosis) 05/2022 - 09/2006
7	Connective Tissue Diseases (Connective Tissue Disease) 02/2022 - 12/2010
6	Pulmonary Hypertension 01/2021 - 06/2007
6	Neoplasms (Cancer) 01/2021 - 06/2007
6	digital ulcers 11/2018 - 05/2006
5	Diffuse Scleroderma (Progressive Systemic Sclerosis) 12/2020 - 06/2015
5	Ulcer 12/2015 - 05/2006
4	Ischemia 01/2022 - 01/2010
4	Wounds and Injuries (Trauma) 01/2022 - 06/2007
4	Infections 12/2020 - 06/2007
4	Autoimmune Diseases (Autoimmune Disease) 01/2020 - 04/2004
4	Skin Diseases (Skin Disease) 01/2018 - 06/2007
4	Pain (Aches) 12/2015 - 06/2007
3	Calcinosis Cutis 02/2022 - 11/2015
3	Melanoma (Melanoma, Malignant) 02/2022 - 07/2011
3	Myositis (Idiopathic Inflammatory Myopathies) 06/2020 - 09/2012
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2018 - 06/2014
3	Telangiectasis (Telangiectasia) 06/2014 - 11/2013
3	Raynaud Disease (Raynaud's Disease) 06/2014 - 06/2007
3	Arthritis (Polyarthritis) 07/2011 - 06/2007
2	Hypoxia (Hypoxemia) 02/2022 - 11/2018
2	Polymyositis 02/2022 - 04/2004
2	Sclerosis 02/2022 - 02/2009
2	Pericardial Effusion 01/2019 - 12/2010
2	Dyspnea (Shortness of Breath) 01/2019 - 03/2013
2	Acro-Osteolysis (Acroosteolysis) 11/2018 - 11/2015
2	Fatigue 01/2018 - 01/2016
2	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2018 - 04/2008
2	Headache (Headaches) 01/2016 - 03/2009
2	Mixed Connective Tissue Disease (MCTD) 12/2013 - 12/2010
2	Hyperuricemia 07/2012 - 04/2011
1	Muscular Diseases (Myopathy) 02/2022
1	Diarrhea 03/2021
1	Gastric Antral Vascular Ectasia (Watermelon Stomach) 10/2020
1	Rare Diseases (Rare Disease) 01/2020
1	Anemia 01/2019
1	Chronic Disease (Chronic Diseases) 01/2018
1	Rupture 01/2018
1	Deglutition Disorders (Dysphagia) 12/2017
1	Myalgia 12/2017
1	Edema (Dropsy) 12/2017

Drug/Important Bio-Agent (IBA)

12	AutoantibodiesIBA 02/2022 - 06/2011
10	AntibodiesIBA 10/2020 - 04/2004
7	CalciumIBA 02/2022 - 07/2014
4	Rituximab (Mabthera)FDA Link 01/2021 - 11/2006
3	CytokinesIBA 05/2022 - 06/2011
3	ametantrone (HAQ)IBA 01/2022 - 03/2013
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 12/2017
3	beta-cyclodextrin tetradecasulfate (CTDS)IBA 01/2021 - 12/2010
3	Abatacept (Orencia)FDA Link 12/2020 - 06/2015
3	tocilizumab (atlizumab)FDA Link 01/2018 - 06/2016
3	Carbon MonoxideIBA 08/2014 - 12/2010
3	Endothelin Receptor AntagonistsIBA 08/2014 - 06/2007
2	Biomarkers (Surrogate Marker)IBA 05/2022 - 06/2020
2	Phosphates (Orthophosphate)IBA 02/2022 - 06/2020
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 01/2022 - 01/2010
2	treprostinil FDA Link 01/2022 - 05/2006
2	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021 - 06/2007
2	ChromatinIBA 12/2020 - 11/2020
2	RNA Polymerase IIIIBA 10/2020 - 12/2016
2	CollagenIBA 04/2020 - 01/2013
2	anticentromere antibodyIBA 11/2018 - 11/2015
2	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2017 - 12/2010
2	7-(N-(3-aminopropyl)amino)heptan-2-oneIBA 12/2014 - 12/2010
2	Uric Acid (Urate)IBA 07/2012 - 04/2011
1	Oncostatin MIBA 05/2022
1	Monoclonal AntibodiesIBA 05/2022
1	Biological ProductsIBA 05/2022
1	carboapatiteIBA 02/2022
1	MineralsIBA 02/2022
1	Durapatite (Hydroxylapatite)IBA 02/2022
1	Calcium CompoundsIBA 01/2022
1	sodium thiosulfate FDA Link 01/2022
1	Minocycline (Cyclops)FDA LinkGeneric 01/2022
1	Phosphorus (Red Phosphorus)IBA 01/2022
1	Vasodilator Agents (Vasodilators)IBA 01/2022
1	nintedanibIBA 03/2021
1	Pharmaceutical PreparationsIBA 02/2021
1	Prednisone (Sone)FDA LinkGeneric 01/2021
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2021
1	DNA (Deoxyribonucleic Acid)IBA 11/2020
1	SaltsIBA 06/2020
1	lenabasum (ajulemic acid)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2020
1	Oxygen (Dioxygen)IBA 01/2019
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2018
1	nuclear matrix protein 2IBA 12/2017
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 12/2017

Therapy/Procedure

15	Therapeutics 01/2022 - 05/2006
2	Length of Stay 01/2018 - 04/2008
2	Sympathectomy (Sympathectomies) 12/2015 - 09/2015
1	Immunomodulation 07/2022
1	Activities of Daily Living (ADL) 01/2020